Can a 60-year-old diet pill work for years? new study aims to find out.

NCT ID NCT05176626

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether the weight-loss drug phentermine, currently approved for only 12 weeks, can be safely used for up to 2 years. About 870 adults with obesity will take phentermine and receive online lifestyle coaching. Researchers will track weight loss, blood pressure, and other health measures to see if long-term use is effective and safe.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
phentermine
What this could lead to
If successful, this could show that phentermine is safe and effective for long-term weight management, supporting its use beyond the current 12-week limit.
What could go wrong
This is a Phase 4 trial, but phentermine has known risks like increased blood pressure and heart rate. Long-term safety data are still limited, and weight loss may not be sustained in all participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIFESTYLE, HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Atrium Health Wake Forest Baptist Weight Management Center

    Winston-Salem, North Carolina, 27104, United States

  • HealthPartners Institute

    Saint Louis Park, Minnesota, 55416, United States

  • Kaiser Permanente Southern California

    Los Angeles, California, 90034, United States

  • UT Center for Obesity Medicine and Metabolic Performance

    Bellaire, Texas, 77401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.